Author(s)Goldschmidt H, Moreau P, Ludwig H, et al. Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ...
Acute COVID-19 illness complications include stroke, encephalopathies, neuropsychiatric and inflammatory syndromes, whereas non-severe cases may suffer from longitudinal brain structure and cognition ...
A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma ...
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, ...
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial CASTOR was a multicenter, randomized, open ...
A potential COVID-19 treatment is delivering promising results in clinical trials, with dexamethasone helping cut deaths in cases of severe respiratory complications. The potential of the drug, a ...
Alfred L. Garfall, MD, discusses follow-up data from the DREAMM-8 study presented at ASCO 2024. Please provide your key takeaways from this study.How might these findings impact the management of ...
The IMiD lenalidomide has shown promising results as a single agent 16 as well as in combination with other active agents for the treatment of MM. 15, 17, 18, 19, 20 ...
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving ...
A dexamethasone-sparing regimen of daratumumab and lenalidomide was safe and effective in older, frail patients with newly diagnosed multiple myeloma. Among that select group of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results